Sho Uemura

Closest collaborators

The 25 strongest of 38 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Minoru Kitago · 9 shared papers, 2022–2026 · strength 1.81
   • Paper Impact of Sarcopenia During Induction Treatment in Patients With Unresectable Locally Advanced Pancreatic Cancer. DOI 10.1002/ags3.70078↗
   • Paper Preoperative CD44v6-positive extracellular vesicles as a prognostic biomarker in pancreatic ductal adenocarcinoma. DOI 10.1007/s00535-026-02343-2↗
   • Paper A Pancreatic Ductal Adenocarcinoma Diagnostic System Using Serum Extracellular Vesicle Detection with Optimized Lectin … DOI 10.3390/cancers18060924↗
2. Yutaka Nakano · 5 shared papers, 2022–2026 · strength 1.06
   • Paper Impact of Sarcopenia During Induction Treatment in Patients With Unresectable Locally Advanced Pancreatic Cancer. DOI 10.1002/ags3.70078↗
   • Paper Preoperative CD44v6-positive extracellular vesicles as a prognostic biomarker in pancreatic ductal adenocarcinoma. DOI 10.1007/s00535-026-02343-2↗
   • Paper Efficacy and safety of chemoradiotherapy using gemcitabine plus nab-paclitaxel for unresectable locally advanced pancre… DOI 10.21203/rs.3.rs-4671932/v1↗
3. Yuko Kitagawa · 4 shared papers, 2024–2026 · strength 1.00
   • Paper Impact of Sarcopenia During Induction Treatment in Patients With Unresectable Locally Advanced Pancreatic Cancer. DOI 10.1002/ags3.70078↗
   • Paper Preoperative CD44v6-positive extracellular vesicles as a prognostic biomarker in pancreatic ductal adenocarcinoma. DOI 10.1007/s00535-026-02343-2↗
   • Paper A Pancreatic Ductal Adenocarcinoma Diagnostic System Using Serum Extracellular Vesicle Detection with Optimized Lectin … DOI 10.3390/cancers18060924↗
4. Shutaro Hori · 4 shared papers, 2024–2026 · strength 0.95
   • Paper Impact of Sarcopenia During Induction Treatment in Patients With Unresectable Locally Advanced Pancreatic Cancer. DOI 10.1002/ags3.70078↗
   • Paper Preoperative CD44v6-positive extracellular vesicles as a prognostic biomarker in pancreatic ductal adenocarcinoma. DOI 10.1007/s00535-026-02343-2↗
   • Paper Efficacy and safety of chemoradiotherapy using gemcitabine plus nab-paclitaxel for unresectable locally advanced pancre… DOI 10.21203/rs.3.rs-4671932/v1↗
5. Yuta Abe · 4 shared papers, 2024–2026 · strength 0.95
   • Paper Impact of Sarcopenia During Induction Treatment in Patients With Unresectable Locally Advanced Pancreatic Cancer. DOI 10.1002/ags3.70078↗
   • Paper Preoperative CD44v6-positive extracellular vesicles as a prognostic biomarker in pancreatic ductal adenocarcinoma. DOI 10.1007/s00535-026-02343-2↗
   • Paper Efficacy and safety of chemoradiotherapy using gemcitabine plus nab-paclitaxel for unresectable locally advanced pancre… DOI 10.21203/rs.3.rs-4671932/v1↗
6. Yohei Masugi · 5 shared papers, 2022–2026 · strength 0.89
   • Paper Preoperative CD44v6-positive extracellular vesicles as a prognostic biomarker in pancreatic ductal adenocarcinoma. DOI 10.1007/s00535-026-02343-2↗
   • Paper Prognostic model for pancreatic cancer based on machine learning of routine slides and transcriptomic tumor analysis. DOI 10.1038/s41416-025-03308-7↗
   • Paper Blood Group Antigen Expression in Blood and Tumor in Relation to Survival Outcomes in Resected Pancreatic Cancer, Overa… DOI 10.1245/s10434-025-17289-7↗
7. Masayuki Tanaka · 3 shared papers, 2024–2026 · strength 0.69
   • Paper Impact of Sarcopenia During Induction Treatment in Patients With Unresectable Locally Advanced Pancreatic Cancer. DOI 10.1002/ags3.70078↗
   • Paper Efficacy and safety of chemoradiotherapy using gemcitabine plus nab-paclitaxel for unresectable locally advanced pancre… DOI 10.21203/rs.3.rs-4671932/v1↗
   • Paper Prognosis prediction of PDAC via detection of O-glycan altered extracellular vesicles in perioperative sera. DOI 10.1111/cas.16341↗
8. Yosuke Uematsu · 3 shared papers, 2025–2026 · strength 0.65
   • Paper Preoperative CD44v6-positive extracellular vesicles as a prognostic biomarker in pancreatic ductal adenocarcinoma. DOI 10.1007/s00535-026-02343-2↗
   • Paper Prognostic model for pancreatic cancer based on machine learning of routine slides and transcriptomic tumor analysis. DOI 10.1038/s41416-025-03308-7↗
   • Paper Blood Group Antigen Expression in Blood and Tumor in Relation to Survival Outcomes in Resected Pancreatic Cancer, Overa… DOI 10.1245/s10434-025-17289-7↗
9. Yosuke Inoue · 4 shared papers, 2022–2026 · strength 0.63
   • Paper Prognostic model for pancreatic cancer based on machine learning of routine slides and transcriptomic tumor analysis. DOI 10.1038/s41416-025-03308-7↗
   • Paper Blood Group Antigen Expression in Blood and Tumor in Relation to Survival Outcomes in Resected Pancreatic Cancer, Overa… DOI 10.1245/s10434-025-17289-7↗
   • Paper Post-operative mortality and recurrence patterns in pancreatic cancer according to KRAS mutation and CDKN2A, p53, and S… DOI 10.1002/cjp2.323↗
10. Kiyoshi Hasegawa · 4 shared papers, 2022–2026 · strength 0.63
    • Paper Prognostic model for pancreatic cancer based on machine learning of routine slides and transcriptomic tumor analysis. DOI 10.1038/s41416-025-03308-7↗
    • Paper Blood Group Antigen Expression in Blood and Tumor in Relation to Survival Outcomes in Resected Pancreatic Cancer, Overa… DOI 10.1245/s10434-025-17289-7↗
    • Paper Post-operative mortality and recurrence patterns in pancreatic cancer according to KRAS mutation and CDKN2A, p53, and S… DOI 10.1002/cjp2.323↗
11. Manabu Takamatsu · 4 shared papers, 2022–2026 · strength 0.63
    • Paper Prognostic model for pancreatic cancer based on machine learning of routine slides and transcriptomic tumor analysis. DOI 10.1038/s41416-025-03308-7↗
    • Paper Blood Group Antigen Expression in Blood and Tumor in Relation to Survival Outcomes in Resected Pancreatic Cancer, Overa… DOI 10.1245/s10434-025-17289-7↗
    • Paper Post-operative mortality and recurrence patterns in pancreatic cancer according to KRAS mutation and CDKN2A, p53, and S… DOI 10.1002/cjp2.323↗
12. Tsuyoshi Takeda · 4 shared papers, 2022–2026 · strength 0.63
    • Paper Prognostic model for pancreatic cancer based on machine learning of routine slides and transcriptomic tumor analysis. DOI 10.1038/s41416-025-03308-7↗
    • Paper Blood Group Antigen Expression in Blood and Tumor in Relation to Survival Outcomes in Resected Pancreatic Cancer, Overa… DOI 10.1245/s10434-025-17289-7↗
    • Paper Post-operative mortality and recurrence patterns in pancreatic cancer according to KRAS mutation and CDKN2A, p53, and S… DOI 10.1002/cjp2.323↗
13. Tatsunori Suzuki · 4 shared papers, 2022–2026 · strength 0.63
    • Paper Prognostic model for pancreatic cancer based on machine learning of routine slides and transcriptomic tumor analysis. DOI 10.1038/s41416-025-03308-7↗
    • Paper Blood Group Antigen Expression in Blood and Tumor in Relation to Survival Outcomes in Resected Pancreatic Cancer, Overa… DOI 10.1245/s10434-025-17289-7↗
    • Paper Post-operative mortality and recurrence patterns in pancreatic cancer according to KRAS mutation and CDKN2A, p53, and S… DOI 10.1002/cjp2.323↗
14. Tsuyoshi Hamada · 4 shared papers, 2022–2026 · strength 0.63
    • Paper Prognostic model for pancreatic cancer based on machine learning of routine slides and transcriptomic tumor analysis. DOI 10.1038/s41416-025-03308-7↗
    • Paper Blood Group Antigen Expression in Blood and Tumor in Relation to Survival Outcomes in Resected Pancreatic Cancer, Overa… DOI 10.1245/s10434-025-17289-7↗
    • Paper Post-operative mortality and recurrence patterns in pancreatic cancer according to KRAS mutation and CDKN2A, p53, and S… DOI 10.1002/cjp2.323↗
15. Yu Takahashi · 4 shared papers, 2022–2026 · strength 0.63
    • Paper Prognostic model for pancreatic cancer based on machine learning of routine slides and transcriptomic tumor analysis. DOI 10.1038/s41416-025-03308-7↗
    • Paper Blood Group Antigen Expression in Blood and Tumor in Relation to Survival Outcomes in Resected Pancreatic Cancer, Overa… DOI 10.1245/s10434-025-17289-7↗
    • Paper Post-operative mortality and recurrence patterns in pancreatic cancer according to KRAS mutation and CDKN2A, p53, and S… DOI 10.1002/cjp2.323↗
16. Yousuke Nakai · 4 shared papers, 2022–2026 · strength 0.63
    • Paper Prognostic model for pancreatic cancer based on machine learning of routine slides and transcriptomic tumor analysis. DOI 10.1038/s41416-025-03308-7↗
    • Paper Blood Group Antigen Expression in Blood and Tumor in Relation to Survival Outcomes in Resected Pancreatic Cancer, Overa… DOI 10.1245/s10434-025-17289-7↗
    • Paper Post-operative mortality and recurrence patterns in pancreatic cancer according to KRAS mutation and CDKN2A, p53, and S… DOI 10.1002/cjp2.323↗
17. Mitsuhiro Fujishiro · 4 shared papers, 2022–2026 · strength 0.63
    • Paper Prognostic model for pancreatic cancer based on machine learning of routine slides and transcriptomic tumor analysis. DOI 10.1038/s41416-025-03308-7↗
    • Paper Blood Group Antigen Expression in Blood and Tumor in Relation to Survival Outcomes in Resected Pancreatic Cancer, Overa… DOI 10.1245/s10434-025-17289-7↗
    • Paper Post-operative mortality and recurrence patterns in pancreatic cancer according to KRAS mutation and CDKN2A, p53, and S… DOI 10.1002/cjp2.323↗
18. Naoki Sasahira · 4 shared papers, 2022–2026 · strength 0.63
    • Paper Prognostic model for pancreatic cancer based on machine learning of routine slides and transcriptomic tumor analysis. DOI 10.1038/s41416-025-03308-7↗
    • Paper Blood Group Antigen Expression in Blood and Tumor in Relation to Survival Outcomes in Resected Pancreatic Cancer, Overa… DOI 10.1245/s10434-025-17289-7↗
    • Paper Post-operative mortality and recurrence patterns in pancreatic cancer according to KRAS mutation and CDKN2A, p53, and S… DOI 10.1002/cjp2.323↗
19. Tatsuya Kawakami · 2 shared papers, 2024–2026 · strength 0.41
    • Paper A Pancreatic Ductal Adenocarcinoma Diagnostic System Using Serum Extracellular Vesicle Detection with Optimized Lectin … DOI 10.3390/cancers18060924↗
    • Paper Prognosis prediction of PDAC via detection of O-glycan altered extracellular vesicles in perioperative sera. DOI 10.1111/cas.16341↗
20. Yasuaki Kabe · 2 shared papers, 2024–2026 · strength 0.41
    • Paper A Pancreatic Ductal Adenocarcinoma Diagnostic System Using Serum Extracellular Vesicle Detection with Optimized Lectin … DOI 10.3390/cancers18060924↗
    • Paper Prognosis prediction of PDAC via detection of O-glycan altered extracellular vesicles in perioperative sera. DOI 10.1111/cas.16341↗
21. Gaku Shimane · 2 shared papers, 2023–2026 · strength 0.39
    • Paper Preoperative CD44v6-positive extracellular vesicles as a prognostic biomarker in pancreatic ductal adenocarcinoma. DOI 10.1007/s00535-026-02343-2↗
    • Paper Post-operative mortality and recurrence patterns in pancreatic cancer according to KRAS mutation and CDKN2A, p53, and S… DOI 10.1002/cjp2.323↗
22. Michiie Sakamoto · 2 shared papers, 2022–2023 · strength 0.24
    • Paper Post-operative mortality and recurrence patterns in pancreatic cancer according to KRAS mutation and CDKN2A, p53, and S… DOI 10.1002/cjp2.323↗
    • Paper KRAS variant allele frequency, but not mutation positivity, associates with survival of patients with pancreatic cancer. DOI 10.1111/cas.15398↗
23. Ayumi Kashiro · 1 shared paper, 2026 · strength 0.23
    • Paper A Pancreatic Ductal Adenocarcinoma Diagnostic System Using Serum Extracellular Vesicle Detection with Optimized Lectin … DOI 10.3390/cancers18060924↗
24. Mutsuo Furihata · 1 shared paper, 2026 · strength 0.23
    • Paper A Pancreatic Ductal Adenocarcinoma Diagnostic System Using Serum Extracellular Vesicle Detection with Optimized Lectin … DOI 10.3390/cancers18060924↗
25. Atsushi Kuno · 1 shared paper, 2026 · strength 0.23
    • Paper A Pancreatic Ductal Adenocarcinoma Diagnostic System Using Serum Extracellular Vesicle Detection with Optimized Lectin … DOI 10.3390/cancers18060924↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.